Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease

被引:54
作者
Sonmez, Alper [1 ]
Nikolic, Dragana [2 ]
Dogru, Teoman [3 ]
Ercin, Cemal Nunri [3 ]
Genc, Halil [3 ]
Cesur, Mustafa [4 ]
Tapan, Serkan [5 ]
Karslioglu, Yildirim [6 ]
Montalto, Giuseppe [2 ]
Banach, Maciej [7 ]
Toth, Peter P. [8 ,9 ,10 ]
Bagci, Sait [3 ]
Rizzo, Manfredi [2 ,11 ]
机构
[1] Gulhane Mil Med Acad, Dept Endocrinol & Metab Dis, Ankara, Turkey
[2] Univ Palermo, BioMed Dept Internal Med & Med Specialties, I-90133 Palermo, Italy
[3] Gulhane Mil Med Acad, Dept Gastroenterol, Ankara, Turkey
[4] Ankara Guven Hosp, Dept Endocrinol, Ankara, Turkey
[5] Gulhane Mil Med Acad, Dept Med Biochem, Ankara, Turkey
[6] Gulhane Mil Med Acad, Dept Pathol, Ankara, Turkey
[7] Med Univ Lodz, Dept Hypertens & Nephrol, Lodz, Poland
[8] CGH Med Ctr, Dept Prevent Cardiol, Sterling, IL 61081 USA
[9] Univ Illinois, Dept Family & Community Med, Sch Med, Peoria, IL USA
[10] Johns Hopkins Univ, Sch Med, Ciccarone Ctr Cardiovasc Dis Prevent, Baltimore, MD USA
[11] Euromediterranean Inst Sci & Technol, Palermo, Italy
关键词
Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Simple steatosis; Lipids; Lipoproteins; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR RISK; METABOLIC SYNDROME; HEPATIC STEATOSIS; FETUIN-A; PLASMA; ATHEROSCLEROSIS; ASSOCIATION; SEVERITY; DYSLIPIDEMIA;
D O I
10.1016/j.jacl.2015.03.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is associated with increased cardiometabolic risk. Although dyslipidemia represents a key factor in this disease, its impact on serum levels of distinct lipoprotein subfractions is largely unknown. OBJECTIVE: To assess the full low-density lipoprotein (LDL) and high-density lipoprotein (I-EDL) profiles in patients with NAFLD. METHODS: Seven LDL and 10 HDL subfractions were assessed by gel electrophoresis (Lipoprint, Quantimetrix Corporation, USA) in men with biopsy proven NAFLD (simple steatosis [n = 17, age, 34 7 years] and nonalcoholic steatohepatitis [NASH; n = 24, age, 32 +/- 6 years]). Exclusion criteria included robust alcohol consumption, infection with hepatitis B or C virus, body mass index >= 40 kg/m(2), diabetes mellitus, and hypertension. RESULTS: Compared with simple steatosis, NASH patients had similar body mass index, homeostasis model assessment of insulin resistance index and plasma lipids, with increased levels of.both aspartate aminotransferase and alanine transaminase. NASH subjects had lower levels of larger LDL1 (10 4 vs 13 4%, P =.010) and increased smaller LDL3 and LDL4 particles (9 5 vs 5 5%, P =.017 and 3 3 vs 1 2%, P =.012, respectively). No changes were found in the HDL subclass profile. By multiple regression analysis, we found that NASH was associated only with increased levels of LDL3 (P =.0470). CONCLUSIONS: The increased levels of small, dense LDL3 and LDL4 in NASH may help to at least partly explain the increased risk for atherosclerosis and cardiovascular diseases in these patients. (C) 2015 National Lipid Association. All rights reserved.
引用
收藏
页码:576 / 582
页数:7
相关论文
共 38 条
[1]  
Abenavoli L, 2014, PANMINERVA MED, V56, P189
[2]   Incidence and natural course of fatty liver in the general population: the dionysos study [J].
Bedogni, Giorgio ;
Miglioli, Lucia ;
Masutti, Flora ;
Castiglione, Anna ;
Croce, Lory Saveria ;
Tiribelli, Claudio ;
Bellentani, Stefano .
HEPATOLOGY, 2007, 46 (05) :1387-1391
[3]   Ezetimibe alone or in combination with simvastatin increases small dense low-density lipoproteins in healthy men: a randomized trial [J].
Berneis, Kaspar ;
Rizzo, Manfredi ;
Berthold, Heiner K. ;
Spinas, Giatgen A. ;
Krone, Wilhelm ;
Gouni-Berthold, Ioanna .
EUROPEAN HEART JOURNAL, 2010, 31 (13) :1633-U46
[4]   Effects of Lipid-Lowering Drugs on High-Density Lipoprotein Subclasses in Healthy Men-A Randomized Trial [J].
Berthold, Heiner K. ;
Rizzo, Manfredi ;
Spenrath, Nadine ;
Montalto, Giuseppe ;
Krone, Wilhelm ;
Gouni-Berthold, Ioanna .
PLOS ONE, 2014, 9 (03)
[5]   Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity - Studies in subjects with various degrees of glucose tolerance and insulin sensitivity [J].
Bonora, E ;
Saggiani, F ;
Targher, G ;
Zenere, MB ;
Alberiche, M ;
Monauni, T ;
Bonadonna, RC ;
Muggeo, M .
DIABETES CARE, 2000, 23 (01) :57-63
[6]   The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology [J].
Chalasani, Naga ;
Younossi, Zobair ;
Lavine, Joel E. ;
Diehl, Anna Mae ;
Brunt, Elizabeth M. ;
Cusi, Kenneth ;
Charlton, Michael ;
Sanyal, Arun J. .
GASTROENTEROLOGY, 2012, 142 (07) :1592-1609
[7]   Nonalcoholic fatty liver disease and serum lipoproteins: The Multi-Ethnic Study of Atherosclerosis [J].
DeFilippis, Andrew Paul ;
Blaha, Michael J. ;
Martin, Seth S. ;
Reed, Robert M. ;
Jones, Steven R. ;
Nasir, Khurram ;
Blumenthal, Roger S. ;
Budoff, Matthew J. .
ATHEROSCLEROSIS, 2013, 227 (02) :429-436
[8]   Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease [J].
Dogru, Teoman ;
Genc, Halil ;
Tapan, Serkan ;
Aslan, Fatih ;
Ercin, Cemal Nuri ;
Ors, Fatih ;
Kara, Muammer ;
Sertoglu, Erdim ;
Karslioglu, Yildirim ;
Bagci, Sait ;
Kurt, Ismail ;
Sonmez, Alper .
CLINICAL ENDOCRINOLOGY, 2013, 78 (05) :712-717
[9]   Elevated asymmetric dimethylarginine in plasma: An early marker for endothelial dysfunction in non-alcoholic fatty liver disease? [J].
Dogru, Teoman ;
Genc, Halil ;
Tapan, Serkan ;
Ercin, Cemal Nuri ;
Ors, Fatih ;
Aslan, Fatih ;
Kara, Muammer ;
Sertoglu, Erdim ;
Bagci, Sait ;
Kurt, Ismail ;
Sonmez, Alper .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 96 (01) :47-52
[10]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499